Effect of coadministration of omega-3 fatty acids with glimepiride on glycemic control, lipid profile, irisin, and sirtuin-1 in type 2 diabetes mellitus patients: a randomized controlled trial.

Werida, Rehab H; Ramzy, Aalaa; Ebrahim, Youssri Nassief; Helmy, Maged Wasfy

Werida, Rehab H; Ramzy, Aalaa; Ebrahim, Youssri Nassief; Helmy, Maged Wasfy.

Afiliação

Werida RH; Clinical Pharmacy & Pharmacy Practice, Faculty of Pharmacy, Damanhour University, Damanhour, 22514, Egypt. rehabwrieda@pharm.dmu.edu.eg.
Ramzy A; Ministry of Health and Population, Damanhour City, Egypt.
Ebrahim YN; Internal Medicine and Diabetes Department, Damanhour Medical National Institute, Damanhour City, Egypt.
Helmy MW; Pharmacology and Toxicology, Faculty of Pharmacy, Damanhour University, Damanhour, 22514, Egypt.

BMC Endocr Disord ; 23(1): 259, 2023 Nov 25.

Article em En | MEDLINE | ID: mdl-38001474

Assuntos

Diabetes Mellitus Tipo 2; Ácidos Graxos Ômega-3; Resistência à Insulina; Humanos; Glicemia/análise; Diabetes Mellitus Tipo 2/tratamento farmacológico; Método Duplo-Cego; Fibronectinas; Hemoglobinas Glicadas; Controle Glicêmico; Insulina/metabolismo; Sirtuína 1

Palavras-chave

Atherogenic index; Glimepiride; Irisin; Omega-3; Sirtuin-1; T2DM

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Resistência à Insulina / Ácidos Graxos Ômega-3 / Diabetes Mellitus Tipo 2 Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google